PCIT v. Merck Ltd. (2020) 185 DTR 401 / 312 CTR 242/ 275 Taxman 181/ ( 2021 ) 434 ITR 596 (Bom.)(HC)

S. 37(1) : Business expenditure–Capital or revenue–Buy back of shares-Held to be revenue expenditure.

Dismissing the appeal of the revenue the court held that The learned Counsel appearing for the parties are agreed that the issue stands concluded by the decision of this Court in CIT v.. Aditya Birla Novo Ltd. 79 Taxmann.com 210, and CIT  v. Hindalco Industries Ltd. (ITA No.1846 of 2010) decided on 7th August, 2012 against the Revenue and in favour of the respondent. (AY. 2010-11)